GlassScriptPhysician profile
Melanie Mier
NPI 1689964538
$4,818.96
in general payments reported to CMS, 2019-2025
41 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $348 · 2021: $337 · 2022: $656 · 2023: $856 · 2024: $1,045 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,944.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $650.03 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $609.04 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $499.74 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $394.63 | 2019-2025 | Repatha, Repatha, Otezla |
| Abbvie INC. | $390.53 | 2021-2024 | |
| Pfizer INC. | $373.82 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.62 | 2022-2024 | |
| Abbott Laboratories | $160.14 | 2021-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $133.14 | 2019-2025 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.19 | 2020-2024 | Ofev |
| Novartis Pharmaceuticals Corporation | $108.56 | 2022-2024 | |
| Glaxosmithkline, LLC. | $107.78 | 2019-2024 | Shingrix, Arexvy |
| Exact Sciences Corporation | $106.66 | 2023-2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $90.07 | 2023-2025 | Rexulti |
| Daiichi Sankyo INC. | $86.90 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Mier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.